Evidence map›Paper›PMID 39895160›Full record

ArticleFuture science OA2025

A phytotherapeutic approach to hinder the resistance against clindamycin by MRSA:

Amal Mayyas, Ali Al-Samydai, Nehaya Al-Karablieh, Waleed A Zalloum, Deniz Al-Tawalbeh, Farah Al-Mamoori, Rula A Amr, Hamdi Al Nsairat, Simone Carradori, Lidia Kamal Al-Halaseh and 1 more

Abstract read
In one paragraph

Article in Future science OA, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Amal MayyasDepartment of Pharmacy, Faculty of Health Sciences, American University of Madaba, Madaba, Jordan.
Ali Al-SamydaiPharmacological and Diagnostic Research Centre, Faculty of Pharmacy, Al-Ahliyya Amman University, Amman, Jordan.
Nehaya Al-KarabliehDepartment of Plant Protection, School of Agriculture, The University of Jordan, Amman, Jordan.
Waleed A ZalloumDepartment of Pharmacy, Faculty of Health Sciences, American University of Madaba, Madaba, Jordan.
Deniz Al-TawalbehDepartment of Medicinal Chemistry and Pharmacognosy, Faculty of Pharmacy, Yarmouk University, Irbid, Jordan.
Farah Al-MamooriDepartment of Pharmaceutical Sciences, Faculty of Pharmacy, Zarqa University, Zarqa, Jordan.
Rula A AmrDepartment of Pharmacy, Faculty of Health Sciences, American University of Madaba, Madaba, Jordan.
Hamdi Al NsairatPharmacological and Diagnostic Research Centre, Faculty of Pharmacy, Al-Ahliyya Amman University, Amman, Jordan.
Simone CarradoriDepartment of Pharmacy "G. d'Annunzio", University of Chieti-Pescara, Chieti, SC, Italy.
Lidia Kamal Al-HalasehDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Mutah University, Al-Karak, Jordan.
Talal AburjaiFaculty of Pharmacy, The University of Jordan, Amman, Jordan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsThis study investigates the potential effects of essential oils (EOs) in enhancing the efficacy of clindamycin against Methicillin-resistant MATERIALS AND

methodsEssential oils commonly used in traditional medicine were tested for their antimicrobial activity against MRSA. The minimum inhibitory concentration (MIC) was determined using

resultsEOs from

conclusionThe study underscores the potential of plant-based therapies to augment the effectiveness of conventional antibiotics like clindamycin in combating MRSA and addressing antibiotic resistance by integrating traditional plant remedies with modern medical approaches.

Indexed as

AgrAAntibiotic resistanceessential oilsMRSAphytotherapyquorum sensing

Identifiers

PMID39895160
PMCPMC11792796

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.